Skeletal Muscle Atrophy in Long COVID: Implications for Glucose Metabolism

Distinct Muscle Protein Degradation Patterns in Long COVID

Recent studies reveal distinct muscle protein degradation patterns in long COVID patients compared to sedentary controls, highlighting a concerning trend in skeletal muscle health and metabolic function. Research indicates that the atrophy observed in these patients is not merely a result of inactivity but may be intricately linked to underlying metabolic dysfunctions, particularly in glucose metabolism.

Comparison of muscle atrophy in long COVID vs. sedentary controls.
Sources: https://www.semanticscholar.org/paper/6b7a6a804be5c7e26132765f2c022aca42b40131 · https://www.semanticscholar.org/paper/229e3b7e845b769f2140c930c43d11a9aea34c69

Understanding the Mechanisms of Muscle Atrophy

The mechanism behind this atrophy appears to be multifaceted. In healthy muscle tissue, glucose transport is primarily facilitated by the glucose transporter type 4 (GLUT4). This transporter is crucial for maintaining proper glucose homeostasis, particularly during muscle contractions. In long COVID patients, reduced expression of GLUT4 has been documented, which may lead to impaired glucose uptake and increased insulin resistance. Mitochondrial dysfunction is another contributing factor, as it compromises the muscle's ability to generate energy efficiently, further exacerbating muscle degradation.

Visual representation of GLUT4's role in glucose metabolism.
Sources: https://www.semanticscholar.org/paper/ffe7580322c8d852253c7dbaa22a6dfc1b259259 · https://www.semanticscholar.org/paper/229e3b7e845b769f2140c930c43d11a9aea34c69

Research Threads on Skeletal Muscle Dysfunction

Several studies converge on the notion that muscle atrophy in long COVID patients differs from conditions induced by mere sedentary behavior. For instance, the research by Charlton et al. (2025) suggests that skeletal muscle properties in long COVID show unique metabolic disruptions compared to those resulting from bed rest, indicating that the underlying mechanisms are more complex than inactivity alone. Additionally, Pérez Castillo et al. (2025) highlight that metabolic conditions such as obesity and type-2 diabetes often correlate with similar patterns of muscle dysfunction, suggesting a shared pathophysiological basis.

Moreover, recent findings by Zhang et al. (2025) emphasize the role of long noncoding RNAs in regulating muscle atrophy and suggest that interventions targeting these pathways could offer therapeutic potentials. This points to a potential research avenue for developing strategies to mitigate muscle degradation in long COVID patients.

Impact of resistance training on muscle health and metabolic function.
Sources: https://www.semanticscholar.org/paper/6b7a6a804be5c7e26132765f2c022aca42b40131 · https://www.semanticscholar.org/paper/ffe7580322c8d852253c7dbaa22a6dfc1b259259

Actionable Self-Study Protocol

To explore the impact of muscle function on glucose metabolism in long COVID, readers can engage in a self-experimentation protocol over 14 days. The intervention involves a structured resistance training program aimed at enhancing muscle strength and potentially increasing GLUT4 expression.

• Intervention: A 14-day resistance training regimen, focusing on major muscle groups at least three times a week.
• Measurement Plan: Monitor changes in fasting blood glucose levels and perform muscle biopsies if feasible to analyze GLUT4 expression.
• Control Window: Maintain a baseline period of 7 days prior to the intervention where no additional exercise is performed.
• Null-Hypothesis Statement: Resistance training will not significantly alter fasting blood glucose levels or GLUT4 expression compared to baseline.

Caveats and Open Questions

While the evidence suggests a strong link between skeletal muscle atrophy in long COVID and glucose metabolism disruptions, several questions remain unanswered. For instance, the long-term effects of resistance training on GLUT4 expression in this population are still unclear. Additionally, the role of other factors, such as inflammation and hormonal changes post-COVID, could significantly influence outcomes. Further research is needed to delineate these pathways and explore additional interventions.

References

1. Yidi Zhang, Teng Wang, Ziang Wang (2025). Functions and Therapeutic Potentials of Long Noncoding RNA in Skeletal Muscle Atrophy and Dystrophy. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13747
2. B. Charlton, Anouk Slaghekke, B. Appelman (2025). Skeletal muscle properties in long COVID and ME/CFS differ from those induced by bed rest. medRxiv. https://doi.org/10.1101/2025.05.02.25326885
3. Íñigo M Pérez Castillo, J. Argiles, R. Rueda (2025). Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved. Reviews in Endocrine & Metabolic Disorders. https://doi.org/10.1007/s11154-025-09954-9
4. Yan Wang, Yushen Lu, Jinhui Hou (2025). Upregulation of FAM129B protects against glucocorticoid-induced skeletal muscle atrophy via regulating long non-coding RNA NEAT1.. International Journal of Biological Macromolecules. https://doi.org/10.1016/j.ijbiomac.2025.140120
5. Lauren Jun, M. Robinson, T. Geetha (2023). Prevalence and Mechanisms of Skeletal Muscle Atrophy in Metabolic Conditions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032973
6. Leng Han, LingJie Jing, Xinting Zhu (2026). Cancer IDO1‐Mediated Tryptophan–Kynurenine Metabolic Reprogramming to Drive Skeletal Muscle Atrophy and Cachexia Acceleration. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70295